case_images: PMC9249528_01
case_images: Duplex ultrasound showing an abnormally shaped AV fistula with associated pseudoaneurysm.
case_images: CRIVAM2022-7005236.001.jpg
case_images: PMC9249528_01_CRIVAM2022-7005236.001.jpg
case_images: fig1
case_images: Duplex ultrasound was performed for imaging (Figure 1).
case_images: Dissection of the arteriovenous fistula and pseudoaneurysm (white borders). Top left is the inguinal ligament, orange borders highlight the common femoral artery, and blue borders highlight femoral vein.
case_images: CRIVAM2022-7005236.002.jpg
case_images: PMC9249528_01_CRIVAM2022-7005236.002.jpg
case_images: fig2
case_images: Surgical exposure identified a common femoral artery to femoral vein AVF with PSA, shown in Figure 2, with contributing branches identified (Figures 2 and 3).
case_images: Views of the arterial and venous connections to the structure. (a) Arterial connection to AV fistula and pseudoaneurysm. (b) Venous connection to AV fistula and pseudoaneurysm.
case_images: CRIVAM2022-7005236.003.jpg
case_images: PMC9249528_01_CRIVAM2022-7005236.003.jpg
case_images: fig3
case_images: Surgical exposure identified a common femoral artery to femoral vein AVF with PSA, shown in Figure 2, with contributing branches identified (Figures 2 and 3). The AVF and PSA were mobilized along with obtaining distal artery and vein control (Figure 3).
case_images: Repair of the AV fistula with pseudoaneurysm. (a) Suture ligation of the venous limb of the structure with AV fistula/pseudoaneurysm remnant. (b) Repaired AV fistula/pseudoaneurysm prior to closing. The common femoral artery is at the top with a great saphenous vein patch sewn in. The femoral vein is at the bottom with the stump ligated.
case_images: CRIVAM2022-7005236.004.jpg
case_images: PMC9249528_01_CRIVAM2022-7005236.004.jpg
case_images: fig4
case_images: The venous end was suture ligated, observing a small opening into the vein (Figure 4). The fistula then divided from the artery and a harvested saphenous vein was sewn to the artery (Figure 4).